FDA Adverse Event Injury Summary report: N

TEXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM

MDR report key: 1220463 · Received November 4, 2008

Report

Report Number
2134265-2008-04185
Event Type
Injury
Date Received
November 4, 2008
Date of Event
October 5, 2008
Report Date
October 8, 2008
Manufacturer
BOSTON SCIENTIFIC
Product Code
NIQ
PMA / PMN Number
P030025
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE COMPLAINANT INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE MANUFACTURING DOCUMENTATION FOR THIS BATCH FOUND THAT THE DEVICE MET ITS MATERIAL, ASSEMBLY AND PRODUCT SPECIFICATIONS AT THE TIME OF RELEASE TO DISTRIBUTION. THE MOST PROBABLE ROOT CAUSE IS DETERMINED TO BE ANTICIPATED PROCEDURAL COMPLICATION, AS THE DEVICE RELATED ROOT CAUSE DOES NOT APPLY AND THE COMPLAINT IS DUE TO A KNOWN PHYSIOLOGICAL EFFECT OF THE PROCEDURE NOTED WITHIN THE DFU, AND/OR DEVICE LABELING.

Description of Event or Problem · 1

IT WAS REPORTED THAT POST A CORONARY DRUG ELUTING STENTING TREATMENT PROCEDURE, A THROMBOSIS OCCURRED. THE PHYSICIAN DIRECT STENTED A TAXUS EXPRESS2 3.5X20MM DRUG ELUTING STENT TO THE 80% STENOSED LESION LOCATED IN THE NONTORTUOUS AND NONCALICIFED PROXIMAL LEFT ANTERIOR DESCENDING (LAD) ARTERY. UPON COMPLETION OF THE PROCEDURE, THE PATIENT EXPERIENCED SEVERE CHEST PAIN AND THE IMPLANTED STENT WAS FOUND TO BE FULL OF THROMBUS. ALL ATTEMPTS TO DISSOLVE THE THROMBUS BY INJECTING RELATED ANTIPLATELET MEDICATION, SUCH AS HEPARIN, WERE NOT SUCCESSFUL. THE PATIENT WAS SENT FOR EMERGENT CORONARY ARTERY BYPASS GRAFTING (CABG) SURGERY. ADDITIONAL INFORMATION REGARDING THIS EVENT HAS BEEN REQUESTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TEXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM NIQ STENT, CORONARY, DRUG-ELUTING NIQ BOSTON SCIENTIFIC 3.5X20MM 11820978

Patients

Seq Age Sex Outcome Treatment
1 70 YR Required Intervention